Cargando…

A Radionuclide Generator of High-Purity Bi-213 for Instant Labeling

A new two-column (225)Ac/(213)Bi generator was developed specifically for using (225)Ac containing an impurity of long lived (227)Ac. The parent (225)Ac was retained on the first Actinide Resin column, while (213)Bi was accumulated on the second column filled with AG MP-50 resin via continuous eluti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ermolaev, Stanislav, Skasyrskaya, Aino, Vasiliev, Aleksandr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234463/ https://www.ncbi.nlm.nih.gov/pubmed/34205580 http://dx.doi.org/10.3390/pharmaceutics13060914

Ejemplares similares

Rapid Elution of (226)Th from a Two-Column (230)U/(226)Th Generator with Diluted and Buffer Solutions
por: Ermolaev, Stanislav V., et al.
Publicado: (2023)

In Vitro comparison of (213)Bi- and (177)Lu-radiation for peptide receptor radionuclide therapy
por: Chan, Ho Sze, et al.
Publicado: (2017)

High-throughput instant quantification of protein expression and purity based on photoactive yellow protein turn off/on label
por: Kim, Youngmin, et al.
Publicado: (2013)

(213)Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer
por: Sathekge, Mike, et al.
Publicado: (2017)

Long-Term Toxicity of (213)Bi-Labelled BSA in Mice
por: Dorso, Laëtitia, et al.
Publicado: (2016)

Level structure in $^{213}Bi$
por: Chumin, V G, et al.
Publicado: (1996)

Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside
por: Ahenkorah, Stephen, et al.
Publicado: (2021)

First‐Generation Bispidine Chelators for (213)Bi(III) Radiopharmaceutical Applications
por: Bruchertseifer, Frank, et al.
Publicado: (2020)

Studies of $\alpha$-spectra in $^{221}Fr, ^{217}At, ^{213}Bi$ and $^{213}Po$ decays
por: Chumin, V G, et al.
Publicado: (1997)

Therapeutic Performance Evaluation of (213)Bi-Labelled Aminopeptidase N (APN/CD13)-Affine NGR-Motif ([(213)Bi]Bi-DOTAGA-cKNGRE) in Experimental Tumour Model: A Treasured Tailor for Oncology
por: Képes, Zita, et al.
Publicado: (2023)

(213)Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
por: Kratochwil, C., et al.
Publicado: (2014)

Methods of Increasing the Performance of Radionuclide Generators Used in Nuclear Medicine: Daughter Nuclide Build-Up Optimisation, Elution-Purification-Concentration Integration, and Effective Control of Radionuclidic Purity
por: Le, Van So, et al.
Publicado: (2014)

Optimizing labelling conditions of (213)Bi-DOTATATE for preclinical applications of peptide receptor targeted alpha therapy
por: Chan, Ho Sze, et al.
Publicado: (2016)

Radioimmunotherapy of micrometastases in lung with vascular targeted(213)Bi
por: Kennel, S J, et al.
Publicado: (1999)

Radium and Francium beam tests to produce 225Ac/ 213Bi generators at CERN-MEDICIS
por: Bruchertseifer, Frank, et al.
Publicado: (2015)

Cascaded metasurfaces for high-purity vortex generation
por: Mei, Feng, et al.
Publicado: (2023)

Study of (213)Bi and (211)Pb Recoils Release from (223)Ra Labelled TiO(2) Nanoparticles
por: Kozempel, Ján, et al.
Publicado: (2022)

Instant labeling of therapeutic cells for multimodality imaging
por: Nejadnik, Hossein, et al.
Publicado: (2020)

Preclinical studies of targeted α therapy for breast cancer using (213)Bi-labelled-plasminogen activator inhibitor type 2
por: Allen, B J, et al.
Publicado: (2003)

A high-purity $^{82}$Sr/$^{82}$Rb generator
por: Beyer, Gerd-Jürgen, et al.
Publicado: (1990)

Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the (213)Bi-labeled monoclonal antibody MX35 in an ovarian cancer model
por: Gustafsson-Lutz, Anna, et al.
Publicado: (2017)

An Experimental Generator for Production of High-Purity (212)Pb for Use in Radiopharmaceuticals
por: Li, Ruth Gong, et al.
Publicado: (2023)

Characterization of SnO(2)-based (68)Ge/(68)Ga generators and (68)Ga-DOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancy
por: Sudbrock, Ferdinand, et al.
Publicado: (2014)

An innovative gamma-ray spectrometry system using a compact and portable CZT detector for radionuclidic purity tests of PET radiopharmaceuticals
por: Vichi, Sara, et al.
Publicado: (2016)

Diverse metabolic response of cancer cells treated with a (213)Bi-anti-EGFR-immunoconjugate
por: Feuerecker, Benedikt, et al.
Publicado: (2021)

Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide (213)Bi-DTPA-[F3](2) into the Nucleus of Tumor Cells
por: Drecoll, Enken, et al.
Publicado: (2009)

In Vivo Radionuclide Generators for Diagnostics and Therapy
por: Edem, Patricia E., et al.
Publicado: (2016)

High purity carbon foils
por: Veeck, A C, et al.
Publicado: (1995)

Preparation of Sulfur of High Purity
por: Murphy, Thomas J., et al.
Publicado: (1960)

Characterization of High Purity Silicides
por: Seegopaul, Purneshwar, et al.
Publicado: (1988)

Imaging of Tumor Hypoxia With Radionuclide-Labeled Tracers for PET
por: Huang, Yuan, et al.
Publicado: (2021)

Radiopharmaceuticals and other compounds labelled with short-lived radionuclides
por: Welch, Michael J
Publicado: (2013)

Alpha-Particle Emitting (213)Bi-Anti-EGFR Immunoconjugates Eradicate Tumor Cells Independent of Oxygenation
por: Wulbrand, Christian, et al.
Publicado: (2013)

Instant offices
Publicado: (1998)

Instant ACID
por: Rofrano, John, et al.
Publicado: (2005)

Instant Automapper
por: Bhatti, Taswar
Publicado: (2013)

Instant houses /
Publicado: (2018)

El instante
por: Kierkegaard, Søren, 1813-1855
Publicado: (2006)

Instant Mockito
por: Grzejszczak, Marcin
Publicado: (2013)

Instant GSON
por: Patel, Sandeep Kumar
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3gej2alvha2d9lifnrp5ittonn